E
Editas Medicine, Inc.
EDIT · NASDAQ · Healthcare · 433M
Closing price
$2.90
+2.11% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
9.4×
Enterprise value / EBITDAEV/EBITDA
-1.3×
Free cash flow yieldFCF yield
-64.4%
Return on equityROE
-586.6%
Operating margin
-245.2%
Net debt / EBITDAbalance-sheet strength
0.5×
Interest coverage
-16.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.